228 related articles for article (PubMed ID: 28787744)
1. Sarilumab (Kevzara) for rheumatoid arthritis.
Med Lett Drugs Ther; 2017 Aug; 59(1527):134-136. PubMed ID: 28787744
[No Abstract] [Full Text] [Related]
2. Profile of sarilumab and its potential in the treatment of rheumatoid arthritis.
Raimondo MG; Biggioggero M; Crotti C; Becciolini A; Favalli EG
Drug Des Devel Ther; 2017; 11():1593-1603. PubMed ID: 28579757
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of tocilizumab combined with cyclosporine A in a patient with rheumatoid arthritis and concomitant chronic hepatitis C virus infection.
Giannitti C; Fineschi I; Frediani B; Fioravanti A; Galeazzi M
Clin Exp Rheumatol; 2013; 31(5):816. PubMed ID: 24021246
[No Abstract] [Full Text] [Related]
4. [Adalimumab].
Kasama T
Nihon Rinsho; 2013 Jul; 71(7):1218-24. PubMed ID: 23961670
[TBL] [Abstract][Full Text] [Related]
5. Toxidermia under treatment with tocilizumab for rheumatoid arthritis.
Fechtenbaum M; Banse C; Boyard-Lasselin P; Goëb V
Joint Bone Spine; 2015 Jan; 82(1):69-70. PubMed ID: 25048098
[No Abstract] [Full Text] [Related]
6. IL-6 targeting compared to TNF targeting in rheumatoid arthritis: studies of olokizumab, sarilumab and sirukumab.
Tanaka Y; Martin Mola E
Ann Rheum Dis; 2014 Sep; 73(9):1595-7. PubMed ID: 24833786
[No Abstract] [Full Text] [Related]
7. Cutaneous sarcoidosis in a patient with rheumatoid arthritis receiving tocilizumab.
Shono Y; Kamata M; Takeoka S; Ikawa T; Tateishi M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Asako K; Kono H; Tada Y
J Dermatol; 2018 Aug; 45(8):e217-e218. PubMed ID: 29500868
[No Abstract] [Full Text] [Related]
8. Long-term safety of sarilumab in rheumatoid arthritis: an integrated analysis with up to 7 years' follow-up.
Fleischmann R; Genovese MC; Lin Y; St John G; van der Heijde D; Wang S; Gomez-Reino JJ; Maldonado-Cocco JA; Stanislav M; Kivitz AJ; Burmester GR
Rheumatology (Oxford); 2020 Feb; 59(2):292-302. PubMed ID: 31312844
[TBL] [Abstract][Full Text] [Related]
9. Visceral leishmaniasis in a patient taking adalimumab for rheumatoid arthritis.
Berry CE; Tsai J; Tierney A; Pickles R
Med J Aust; 2013 Apr; 198(6):331-3. PubMed ID: 23545033
[No Abstract] [Full Text] [Related]
10. Sarcoidosis induced by tocilizumab: a paradoxical event?
Nutz A; Pernet C; Combe B; Cohen JD
J Rheumatol; 2013 Oct; 40(10):1773-4. PubMed ID: 24085760
[No Abstract] [Full Text] [Related]
11. How FABulous is PEGgy? Certoliziumab pegol from the bench to the patients.
Aletaha D
BioDrugs; 2014 Apr; 28 Suppl 1():S3-4. PubMed ID: 24687233
[No Abstract] [Full Text] [Related]
12. Changes in atherosclerosis markers during tocilizumab treatment in rheumatoid arthritis: preliminary results.
Benucci M; Manfredi M; Saviola G; Sarzi-Puttini P; Atzeni F
Clin Exp Rheumatol; 2013; 31(2):322-3. PubMed ID: 23380047
[No Abstract] [Full Text] [Related]
13. A review of sarilumab for the treatment of rheumatoid arthritis.
Lee EB
Immunotherapy; 2018 Jan; 10(1):57-65. PubMed ID: 29043871
[TBL] [Abstract][Full Text] [Related]
14. [Adalimumab induced-inflammatory myopathy in rheumatoid arthritis].
de Souza FH; Barros TB; Levy-Neto M; Shinjo SK
Acta Reumatol Port; 2012; 37(2):180-3. PubMed ID: 23149641
[TBL] [Abstract][Full Text] [Related]
15. Tocilizumab-induced leucocytoclastic vasculitis in a patient with rheumatoid arthritis.
Sakaue S; Sumitomo S; Kubo K; Fujio K; Yamamoto K
Rheumatology (Oxford); 2014 Aug; 53(8):1529-30. PubMed ID: 24609062
[No Abstract] [Full Text] [Related]
16. Cerebral toxoplasmosis following adalimumab treatment in rheumatoid arthritis.
Nardone R; Zuccoli G; Brigo F; Trinka E; Golaszewski S
Rheumatology (Oxford); 2014 Feb; 53(2):284. PubMed ID: 24191065
[No Abstract] [Full Text] [Related]
17. Tumor necrosis factor-α inhibitor-induced antiglomerular basement membrane antibody disease in a patient with rheumatoid arthritis.
Nishimura K; Saegusa J; Kawano S; Morinobu A
J Rheumatol; 2012 Sep; 39(9):1904-5. PubMed ID: 22942311
[No Abstract] [Full Text] [Related]
18. [Clinical effect of tocilizumab on patients with severe active rheumatoid arthritis].
Xu S; Xie X; Tang M; Chen J; Tian J; Du J; Mao N; Liu Y; Li S; Song M; Gao J; Ling G; Li F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 42(10):1174-1177. PubMed ID: 29093249
[TBL] [Abstract][Full Text] [Related]
19. Subclinical inflammation with tocilizumab treatment of rheumatoid arthritis: MRI evaluation for 2 years.
Suzuki T; Hirota T; Ogishima H; Umeda N; Kondo Y; Yokosawa M; Miki H; Tsuboi H; Matsumoto I; Sumida T
Int J Rheum Dis; 2015 Jan; 18(1):108-10. PubMed ID: 25294091
[No Abstract] [Full Text] [Related]
20. Tocilizumab-induced pustular drug eruption.
Mori T; Yamamoto T
Int J Rheum Dis; 2017 Nov; 20(11):1776-1777. PubMed ID: 26218136
[No Abstract] [Full Text] [Related]
[Next] [New Search]
